Monitor for business combination announcements within the 24-month window. The np-SPAC structure eliminates sponsor promote, potentially reducing dilution for public shareholders. Track any target identification and shareholder vote on proposed acquisition.
Executive Summary
Tang Capital Acquisition Corp. (TCAA) filed an amended S-1 for its $75M SPAC IPO, structured as a 'no-promote' SPAC (np-SPAC) where the sponsor will purchase 67% of the offering at the same $25.00/share price as public investors, with no founder shares or warrants. The company has 24 months to complete a business combination, focusing on the biopharmaceutical industry. The filing includes the underwriting agreement, charter documents, and related transaction agreements.
Key Financial Metrics
Key Facts
- IPO of 3,000,000 ordinary shares at $25.00 per share for $75,000,000 in gross proceeds
- Sponsor (Tang Capital Acquisition Holdings, LLC) intends to purchase 2,000,000 shares (67%) at the IPO price for $50 million
- No founder shares, Class B shares, or sponsor warrants — all shares purchased at same $25.00 price
- 24-month completion window to execute initial business combination
- Focus on biopharmaceutical industry for target acquisition
- Underwriters receive 1% upfront commission and 3% deferred commission (payable only upon business combination)
- Shareholders have redemption rights at $25.00 per share plus pro rata surplus interest upon business combination vote or liquidation
- Company has no operating history, no revenue, and no target business identified
Financial Impact
IPO raises $75M gross; $25.00 per share placed in trust for future acquisition or redemption
Risk Factors
- No identified acquisition target — risk of liquidation if no deal within 24 months
- Sponsor's non-binding intention to purchase 67% of shares may not be finalized
- Focus on biopharmaceutical industry carries sector-specific regulatory and clinical risks
- Potential conflicts of interest with Tang Capital affiliates in target selection
- No operating history or revenue — pure shell company with no business operations
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001193125-26-424212 |
| Document: ck0002151808-ex3_2.htm | 0001193125-26-424212 |
| Document: ck0002151808-ex1_1.htm | 0001193125-26-424212 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | S-1/A | — | awaiting T+20 | — | — |
Oct 6, 2026 21d ago | S-1 | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers